Inhibition of fos-jun-DNA complex formation by dihydroguaiaretic acid and in vitro cytotoxic effects on cancer cells

Cancer Letters

Volumn 127, Issue 1-2, 1998, Pages 23-28

  Park, Seyeon ^a   Lee, Dug Keun ^a   Yang, Chul Hak ^a  

^a Seoul National University   (South Korea)

Author keywords

Dihydroguaiaretic acid; Fos jun dimer and DNA complex; Inhibitory effect; Myristica fragrans; Nordihydroguaiaretic acid

Indexed keywords

CURCUMIN; DIMER; DNA; NORDIHYDROGUAIARETIC ACID; NUTMEG OIL; TRANSCRIPTION FACTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ASSAY; BIOASSAY; CANCER CELL CULTURE; COLON CANCER; COMPLEX FORMATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA PROTEIN COMPLEX; DNA SEQUENCE; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; LEUKEMIA; LUNG CANCER; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL;

DIMERIZATION; GUAIACOL; HUMANS; LIGNANS; NORDIHYDROGUAIARETIC ACID; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; TRANSCRIPTION FACTOR AP-1; TUMOR CELLS, CULTURED;

MYRISTICA FRAGRANS;

EID: 0032523890     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00543-0     Document Type: Article

References (25)

1. Curran T., Franza R. Fos and Jun: the AP-1 connection. Cell. 55:1988;395.
2. Johnson P.F., McKnight S.L. Eukaryotic transcriptional regulatory proteins. Annu. Rev. Biochem. 58:1989;799.
3. Mitchell P.J., Tjian R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science. 245:1989;371.
4. Lee W., Mitchell P., Tjian R. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell. 49:1987;741-752.
5. Angel P., Imagawa M., Chiu R., Stein B., Imbra R.J., Rahmsdorf H.J., Jonat C., Herrlich P., Karin M. Phorbol ester-inducible genes contain a common cis-element recognized by a TPA-modulated trans-acting factor. Cell. 49:1987;729-739.
6. Angel P., Hattori K., Smeal T., Karin M. The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell. 55:1988;875-885.
7. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochim. Biophys. Acta. 1072:1991;129-157.
8. Sassone-Corsi P., Verma I.M. Modulation of c-fos gene transcription by negative and positive cellular factors. Nature. 326:1987;507-510.
9. Schutte J., Nau M., Birrer M., Thomas F., Gazdar A., Minna J. Constitutive expression of multiple mRNA forms of the c-jun oncogene in human lung cancer cell lines. Proc. Am. Assoc. Cancer Res. 1808:1988;455.
10. Bossy-Wetzel E., Bravo R., Hanahan D. Transcription factors junB and c-jun are selectively up-regulated and functionally implicated in fibrosarcoma development. Genes Dev. 6:1992;2340-2351.
11. Liehr J.G., Chiappeta C., Roy D., Stancel G.M. Elevation of protooncogene messenger RNAs in estrogen-induced tumors in the kidney. Carcinogenesis. 13:1992;601-604.
12. Schutte J., Minna J.D., Birrer M.J. Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms Rat-1a cells as a single gene. Proc. Natl. Acad. Sci. USA. 86:1989;2257-2261.
13. van der Burg B., van Selm-Miltenburg A.J.P., de Laat S.W., van Zoolen F.J.J. Direct effects of estrogen on c-fos and c-myc protooncogene expression and cellular proliferation in human mammary breast cancer cells. Mol. Cell. Endocrinol. 64:1989;223-228.
14. Baichwal V.R., Tjian R. Control of c-Jun activity by interaction of a cell-specific inhibitor with regulatory domain δ: differences between v- and c-Jun. Cell. 63:1990;815-825.
15. Persson Å.E., Pontén I., Cotgreave I., Jernström B. Inhibitory effects on the DNA binding of AP-1 transcription factor to an AP-1 binding site modified by benzo[α]pyrene 7,8-dihydrodiol 9,10-epoxide diastereomers. Carcinogenesis. 17:1996;1963-1969.
16. Nakatani N., Ikeda K., Kikuzaki H., Kido M., Yamaguchi Y. Diaryldimethylbutane lignans from Myristica argentea and their antimicrobial action against Streptococcus mutants. Phytochemistry. 27:1988;3127-3129.
17. Lee J.Y., Han Y.B., Woo W.S., Shin K.H. Antioxidant activity of diarylbutanes. Korean J. Pharmacogn. 21:1990;270-273.
18. Takaba K., Hirose M., Yosida Y., Kimura J., Ito N., Shirai T. Effects of n-tritriacontane-16,18-dione, curcumin, chlorophyllin, dihydroguaiaretic acid, tannic acid and phytic acid on the initiation stage in a rat multi-organ carcinogenesis model. Cancer Lett. 113:1997;39-46.
19. Huang T.S., Lee S.C., Lin J.K. Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA. 88:1991;5292-5296.
20. Kakar S.S., Roy D. Curcumin inhibits TPA induced expression of c-fos, c-jun and c-myc proto-oncogenes messenger RNAs in mouse skin. Cancer Lett. 87:1994;85-89.
21. Hattori M., Hada S., Shu Y.Z., Kakiuchi N., Namba T. New acyclic bis-phenylpropanoids from the aryls of Myristica fragrans. Chem. Pharm. Bull. 35:1987;668-674.
22. Nakamura N., Kiuchi F., Tsuda Y., Kondo K. Studies on crude drugs effective on visceral larva Migrans. V. Chem. Pharm. Bull. 36:1988;2685-2688.
23. Halazonetis T.D., Georgopoulos K., Greenberg M.E., Leder P. c-jun dimerizes with itself and with c-fos, forming complexes of different DNA binding affinity. Cell. 55:1988;917-924.
24. Sassone-Corsi P., Lamph W.W., Kamps M., Verma I.M. fos-associated cellular p39 is related to nuclear transcription factor AP-1. Cell. 54:1988;553-560.
25. Mattei M.G., Simon-Chazottes D., Hirai S., Ryseck R.P., Galcheva-Gargova Z., Guenet J.L., Mattei J.F., Bravo R., Yaniv M. Chromosomal localization of the three members of the jun proto-oncogene family in mouse and man. Oncogene. 5:1990;151-156.